Skip to main content
. 2025 Jun 13;17(6):775. doi: 10.3390/pharmaceutics17060775
AAVs Adeno-associated viruses
AD Alzheimer’s disease
ASO Antisense oligonucleotide
BBB Blood–brain barrier
BMSCs Bone marrow-derived mesenchymal stem cells
BPD Bronchopulmonary dysplasia
CSF Cerebrospinal fluid
CNS Central nervous system
DPSCs Deciduous dental pulp stem cells
EVs Extracellular vesicles
FUSIN Focused ultrasound-mediated nasal drug delivery
GLP-1 Glucagon-like peptide-1
IGF-1 Insulin-like growth factor 1
hNSCs Human neural stem cells
LIF Leukemia inhibitory factor
MSC Mesenchymal stem cell
NGF Nerve growth factor
OMPCs Olfactory mucosal progenitor cells
PD Parkinson’s disease
PEG Polyethylene glycol
PTD Protein transduction domain
SAD Social anxiety disorder
SCI Spinal cord injury
TBI Traumatic brain injury
ZO-1 Zonula occludens-1